17 results
424B4
EVAX
Evaxion Biotech A/S
5 Nov 21
Prospectus supplement with pricing info
4:47pm
the standards for approval.
Accelerated Approval Pathway and Regenerative Medicine Advanced Therapy Designation
The FDA may grant accelerated approval … by the FDA.
Accelerated approval pathways are available for regenerative medicine therapies that meet certain conditions. Regenerative medicine therapies
F-1/A
EVAX
Evaxion Biotech A/S
3 Nov 21
Registration statement (foreign) (amended)
7:50am
process, but do not change the standards for approval.
Accelerated Approval Pathway and Regenerative Medicine Advanced Therapy Designation
The FDA may … are subject to prior review by the FDA.
Accelerated approval pathways are available for regenerative medicine therapies that meet certain conditions
F-1
craq9ikczx21pp ym
26 Oct 21
Registration statement (foreign)
7:02am
DRS
65p8y0nnbx1 koxfd
25 Jun 21
Draft registration statement
12:00am
20-F
axgchp aqgnslhasm
7 Apr 21
Annual report (foreign)
4:31pm
424B4
us09 o6bz8i8n4j3
5 Feb 21
Prospectus supplement with pricing info
4:53pm
F-1/A
cli19hk1itt40z2e
1 Feb 21
Registration statement (foreign) (amended)
4:56pm
F-1/A
3nspstk lp
25 Jan 21
Registration statement (foreign) (amended)
7:01am
F-1/A
o6x3d25683exj77cb
19 Jan 21
Registration statement (foreign) (amended)
5:05pm
F-1
b61i0qjx
8 Jan 21
Registration statement (foreign)
4:54pm
DRS/A
sh8aush3pv ply
4 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
mmx srp57o
16 Dec 20
Draft registration statement (amended)
12:00am
DRS/A
lez99uz7 h9
25 Nov 20
Draft registration statement (amended)
12:00am
DRS
k84demb
22 Oct 20
Draft registration statement
12:00am
- Prev
- 1
- Next